September 17, 2010 (WLS) -- The FDA says it is reviewing data suggesting a possible link between the diabetes drug Actos and bladder cancer.
The agency says five-year results from an on-going study show patients taking Actos the longest had higher risks of bladder cancer.
Sales of Actos have surged in recent years because it is seen as a safer alternative to Avandia.
The FDA is considering withdrawing Avandia because of potential heart risks.
http://abclocal.go.com/wls/story?section=news/health&id=7674436
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment